Statins and HIV: beyond the metabolic and cardiovascular benefit.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Acquired Immune Deficiency Syndromes

• Publication date

  2005-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.QAI.0000170531.73031.F7PMID 16010178
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Managing Cardiovascular Risk in Patients With HIV Infection

  2005cited by this paper
• Prescribing of Contraindicated Protease Inhibitor and Statin Combinations Among HIV-Infected Persons

  2005cited by this paper
• A prospective trial to evaluate the safety and efficacy of pravastatin for the treatment of refractory chronic graft-versus-host disease.

  2005cited by this paper
• Cardiovascular risk and body-fat abnormalities in HIV-infected adults.

  2005cited by this paper
• Early intervention with atorvastatin modulates TH1/TH2 imbalance in patients with acute coronary syndrome: from bedside to bench.

  2004cited by this paper
• Prospects for an AIDS vaccine: three big questions, no easy answers.

  2004cited by this paper
• High-Dose Atorvastatin Enhances the Decline in Inflammatory Markers in Patients With Acute Coronary Syndromes in the MIRACL Study

  2003cited by this paper
• Inhibition of Hydroxymethylglutaryl-Coenzyme A Reductase Reduces Th1 Development and Promotes Th2 Development

  2003cited by this paper
• Attenuated T-Lymphocyte Response to HIV Therapy in Individuals Receiving HMG-CoA Reductase Inhibitors

  2003cited by this paper
• A Balanced Type 1/Type 2 Response Is Associated with Long-Term Nonprogressive Human Immunodeficiency Virus Type 1 Infection

  2002cited by this paper
• The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

  2002cited by this paper
• Cytokines and HIV-1: Interactions and Clinical Implications

  2001cited by this paper

• Extinguish the Fire: Anti-inflammatory Strategies for Over Immune Activation in Chronic HIV-1 Infection

  2021cites this paper
• Statins in HIV-Infected Patients: Potential Beneficial Effects and Clinical Use.

  2017cites this paper
• The Role of Statins in the Setting of HIV Infection

  2015cites this paper
• Actividad inmunomoduladora y anti-VIH de las estatinas

  2011cites this paper
• Effect of omeprazole on the plasma concentrations of indinavir when administered alone and in combination with ritonavir.

  2008cites this paper
• Atazanavir: simplicity and convenience in different scenarios

  2007cites this paper
• Prolonged statin administration does not act on the cell-mediated immunity of HIV-infected dyslipidemic patients treated with a steady and effective highly active antiretroviral therapy. A two-year prospective study of statin versus fibrate administration.

  2006cites this paper
• Long-term statin use does not act on the temporal trend of CD4 cell count in patients on virologically effective HAART

  2006cites this paper